BioWorld Asia

Sep. 6, 2006

Avidex Moves To Next Stage Via €50M MediGene Merger

LONDON - MediGene AG is acquiring Avidex Ltd. in an all-share deal that values the UK company at €50 million (US$64.3 million). (BioWorld International) Read More

Atlas Antibodies Brings In Seed Money For Human Protein Atlas

Europe Questioning Use Of Advanced Genetic Therapies

Genetix Paying £9.6M Cash To Acquire Applied Imaging

Cerep Subsidiary Hesperion Buys Touchstone Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 18, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Maintenance, man: Lilly’s phase III weight trial hits goals

BioWorld

Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...